visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Akari Therapeutics Plc

    Get Full Access

    Description

    • Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. Akaris lead drug, Coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-C5, preventing release of C5a and formation of C5b 9 (also known as the membrane attack complex or MAC). Coversin is a recombinant small protein (16,740 Da) derived from a native protein discovered in the saliva of the Ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.
    • location

      Headquarters:24 West 40th Street , New York, New York, United States

      More
    • Akari Therapeutics Plc phone

      Phone Number: +1 646-350-0702

    • Akari Therapeutics Plc website

      Website: https://www.akaritx.com

    • Akari Therapeutics Plc employees

      Employees:11

    • Akari Therapeutics Plc revenue

      Revenue:$10 - 50M

    • Akari Therapeutics Plc legal name

      Legal Name:Akari Therapeutics Plc

    • Akari Therapeutics Plc's Social Media

      Akari Therapeutics Plc linkedin
    • done Is this data correct?

    • |  NAICS Code: 325412  |

      Show More
    Person level website identification

    Chief Scientific Officer for Akari Therapeutics Plc

    Miles Nunn

    Chief Scientific Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Miles Nunn

    Chief Scientific Officer

    Stuart Ungar

    Non Executive Director

    Malakeh Mouh

    Clinical Project Manager

    Nekane Aspe

    Senior Project Manager

    Frequently Asked Questions regarding Akari Therapeutics Plc

    • Where are Akari Therapeutics Plc's Headquarters?

      Akari Therapeutics Plc's Headquarters are in 24 West 40th Street ,New York,New York,United States

    • What is Akari Therapeutics Plc's phone number?

      Akari Therapeutics Plc's phone number is +1 646-350-0702

    • What is Akari Therapeutics Plc's official website?

      Akari Therapeutics Plc's official website is https://www.akaritx.com

    • What is Akari Therapeutics Plc's Revenue?

      Akari Therapeutics Plc's revenue is $10 - 50M

    • What is Akari Therapeutics Plc's NAICS code?

      Akari Therapeutics Plc's NAICS code is 325412

    • How many employees are working in Akari Therapeutics Plc

      Akari Therapeutics Plc has 11 employees

    • What is Akari Therapeutics Plc's Industry?

      Akari Therapeutics Plc is in the industry of Biotechnology

    • Who is Akari Therapeutics Plc's Chief Scientific Officer?

      Akari Therapeutics Plc's Chief Scientific Officer is Miles Nunn

    Company Directory